StonvexLoading…
StonvexStonvexStonvexCore line items from BELFA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $178.49M | $675.46M | $499.52M | $320.54M |
Operating Income | $23.67M | $111.00M | $85.22M | $54.88M |
Net Income | $11.38M | $61.54M | $67.67M | $45.12M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $951.92M | $935.20M | $952.80M | $950.58M |
Total Liabilities | $416.21M | $416.53M | $443.77M | $464.87M |
Cash & Equivalents | $59.45M | $57.80M | $57.74M | $59.28M |
Free Cash Flow OCF − CapEx | $11.19M | $68.61M | $42.47M | $22.15M |
Shares Outstanding | Not available | Not available | Not available | Not available |